Top

Published in:

Open Access 01-12-2016 | Editorial

COPD heterogeneity: implications for management

Authors: Miriam Barrecheguren, Marc Miravitlles

Published in: Multidisciplinary Respiratory Medicine | Issue 1/2015

Excerpt

Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous disease and its definition as a disease characterised by a non completely reversible airflow obstruction mainly caused by cigarette smoke does not fully describe the variability in its clinical presentation. …

Rossi A, Aisanov Z, Avdeev S, Di Maria G, Donner CF, Izquierdo JL, et al. Mechanisms, assessment and therapeutic implications of lung hyperinflation in COPD. Respir Med. 2015;109:785–802.CrossRefPubMed

Cooper CB, Barjaktarevic I. A new algorithm for the diagnosis of COPD. Lancet Respir Med. 2015;3:266–8.CrossRefPubMed

Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med. 2010;182:598–604.CrossRefPubMed

Miravitlles M, Calle M, Soler-Cataluña JJ. Clinical phenotypes of COPD: identification, definition and implications for guidelines. Arch Bronconeumol. 2012;48:86–98.PubMed

Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, Quintano JA, et al. Spanish guideline for COPD (GesEPOC) update 2014. Arch Bronconeumol. 2014;50 Suppl 1:1–16.PubMed

Hurst JR, Vestbo J, Anzueto A, Locantore N, Müllerova H, Tal-Singer R, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363:1128–38.CrossRefPubMed

Barrecheguren M, Esquinas C, Miravitlles M. The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges. Curr Opin Pulm Med. 2015;21(1):74–9.CrossRefPubMed

Pavord ID, Lettis S, Locantore N, Pascoe S, Jones PW, Wedzicha JA, et al. Blood eosinophils and inhaled corticosteroids/long acting β-2 agonist efficacy in COPD. Thorax. 2016;71:118–25.CrossRefPubMedPubMedCentral

Pascoe S, Locantore N, Dransfield M, Barnes NC, Pavord ID. Blood eosinophil counts, exacerbations and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomized controlled trials. Lancet Respir Med. 2015;3:435–42.CrossRefPubMed

10.

Barrecheguren M, Román-Rodríguez M, Miravitlles M. Is a previous diagnosis of asthma a reliable criterion for asthma-COPD overlap síndrome in a patient with COPD? Int J Chron Obstruct Pulmon Dis. 2015;10:1745–52.PubMedPubMedCentral

11.

Miravitlles M, Vogelmeier C, Roche N, Halpin D, Cardoso J, Chuchalin AG, et al. A review of national guidelines for management of COPD in Europe. Eur Respir J. 2016;47:625–37.CrossRefPubMedPubMedCentral

12.

Koblizek V, Chlumsky J, Zindr V, Neumannova K, Zatloukal J, Zak J, et al. Chronic Obstructive Pulmonary Disease: official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society: a novel phenotypic approach to COPD with patient oriented care. Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013;157:189–201.

Title: COPD heterogeneity: implications for management
Authors: Miriam Barrecheguren
Marc Miravitlles
Publication date: 01-12-2016
Publisher: BioMed Central
Published in: Multidisciplinary Respiratory Medicine / Issue 1/2015
Electronic ISSN: 2049-6958
DOI: https://doi.org/10.1186/s40248-016-0053-4

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

COPD heterogeneity: implications for management

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2015

Chronic respiratory symptoms and associated factors among cement factory workers in Dejen town, Amhara regional state, Ethiopia, 2015

The BODECOST Index (BCI): a composite index for assessing the impact of COPD in real life

Personality and unachieved treatment goals related to poor adherence to asthma medication in a newly developed adherence questionnaire – a population-based study

Cost of persistent asthma in Italy

Lung disease recalling paraseptal emphysema in a patient with Goltz syndrome

Cost comparison of asthma treatments in 12-week study: caution about matching and short observational follow-up

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page